Balmain, Australia

Catherine Walker

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Marshall Edwards, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine Walker. Retrieved from https://idiyas.com/inventor/catherine-walker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Catherine Walker: Innovator in Oxazinyl Isoflavonoid Compounds

Introduction

Catherine Walker is a notable inventor based in Balmain, Australia. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on oxazinyl isoflavonoid compounds.

Latest Patents

Catherine holds a patent for "Oxazinyl isoflavonoid compounds, medicaments and use." This invention provides oxazinyl isoflavonoid compounds and compositions containing them, along with methods for their preparation. The compounds are recognized for their therapeutic potential, particularly as cardioprotective, anti-inflammatory, anti-oxidant, and chemotherapeutic agents. She has 1 patent to her name.

Career Highlights

Catherine is currently associated with Marshall Edwards, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in exploring new therapeutic avenues for various health conditions.

Collaborations

Catherine has collaborated with notable colleagues, including Andrew Heaton and Naresh Kumar, to further enhance her research initiatives and drive innovation in her field.

Conclusion

Catherine Walker's contributions to the development of oxazinyl isoflavonoid compounds highlight her role as a pioneering inventor in medicinal chemistry. Her work continues to pave the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…